🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Penumbra executive Johanna Roberts sells over $113k in company stock

Published 06/06/2024, 09:36 am
PEN
-

Penumbra Inc 's (NYSE:PEN) EVP, General Counsel & Secretary, Johanna Roberts, has sold a total of $113,338 worth of company stock, according to a recent SEC filing. The transactions took place on June 3, 2024, and were executed under a prearranged 10b5-1 trading plan.

The sales were made at prices ranging from $187.64 to $191.51 per share. This price range represents the weighted average sale prices, which were calculated over multiple trades. The exact number of shares sold at each price point within this range is available upon request from the SEC staff, Penumbra Inc, or a security holder of the issuer.

Following the sales, Johanna Roberts retained ownership of 62,888 shares of Penumbra Inc, some of which are subject to vesting conditions. The transactions signify a notable change in Roberts' holdings in the company, yet they were planned in advance, providing a structured way for the executive to divest shares.

Penumbra Inc, headquartered in Alameda, California, specializes in the development, manufacture, and sale of innovative medical devices. The company is known for its commitment to improving the lives of patients with its products that address challenging medical conditions.

Investors and stakeholders in Penumbra Inc can expect to see how these transactions might influence the company's stock performance in the coming days. The details of the sales are now publicly accessible for those interested in the trading activities of the company's executives.

In other recent news, Penumbra, a healthcare company, disclosed its first-quarter results, with total revenues reaching $278.7 million, marking a 15.4% increase from the previous year. This growth was largely driven by a significant surge of 35.2% in the company's U.S. thrombectomy revenue. Despite some areas of weakness, these results did not raise significant concern for Piper Sandler, which recently adjusted its price target for Penumbra shares to $260 from the previous $290, while maintaining its Overweight rating on the company's stock.

In addition to its financial performance, Penumbra is reportedly making strides in new product development, which Piper Sandler anticipates will support the company's revenue growth in the forthcoming years. The company's management has reaffirmed its full-year guidance, which Piper Sandler considers attainable, although it acknowledges that reaching the mid-point will be challenging.

In terms of future expectations, Penumbra is gearing up for the launch of new products and expects continued margin expansion throughout 2024. The company maintains a strong financial position with $313.5 million in cash and no debt. However, these are not predictions, but recent developments and expectations stated by the company and analysts.

InvestingPro Insights

As Penumbra Inc's (NYSE:PEN) executive Johanna Roberts strategically sold shares, investors may find it useful to consider the company's financial health and market performance. According to InvestingPro data, Penumbra is currently trading at a high earnings multiple with a Price-to-Earnings (P/E) ratio of 79.93, which is above the industry average, indicating that investors are expecting high future growth from the company. The adjusted P/E ratio for the last twelve months as of Q1 2024 stands slightly lower at 69.47.

Despite recent insider selling, Penumbra's fundamentals show a robust financial position. The company's liquid assets exceed its short-term obligations, which demonstrates financial stability and the ability to cover immediate liabilities. Additionally, Penumbra's cash flows can sufficiently cover interest payments, a sign of strong financial health and less risk for debt holders.

Investors are also keeping an eye on Penumbra's market valuation, as the company is trading near its 52-week low with a current price of $190.86, which is 55.44% of its 52-week high. This could indicate potential undervaluation, presenting a buying opportunity for long-term investors. Moreover, the company's revenue growth remains solid, with a 23.87% increase over the last twelve months as of Q1 2024.

For those looking for deeper analysis and additional metrics, there are more InvestingPro Tips available on the platform, providing insights such as the company's profitability outlook and return on assets. Interested readers can explore these expert tips using the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.